RARRES2 and metabolic dysfunction-associated steatotic liver disease: In fact, elevated serum chemerin levels were identified as a risk factor for NAFLD development in T2DM patients [119] and were pointed out as a novel non-invasive serum marker predicting liver steatosis in obese children [120].